Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • Blood Cancer UK (14044)
  • Cancer Research UK (C27995/A9609)
  • Cancer Research UK (C27995/A21019)

This publication has 16 references indexed in Scilit: